SANTA BARBARA, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that members of management are scheduled to present at the 8^th Annual SVB Leerink Global Healthcare Conference in New York, NY.

Audio webcasts of the Company’s presentations will be made available on the investor relations section of Sientra’s web site at http://www.sientra.com. Replays of the presentations will be available for 90 days.

About Sientra
Headquartered in Santa Barbara, California, Sientra is a diversified global medical aesthetics company and a leading partner to aesthetic physicians. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes.   The Company’s Breast Products Segment includes its OPUS™ breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology,  and BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons^(*).  The Company’s miraDry Segment, comprises its miraDry® system, which is approved for sale in over 40 international markets, and is the only non-invasive FDA-cleared device for the permanent reduction of underarm sweat, odor and hair of all colors.
____________________
(*) Data on file

Investor Contacts:
Neil Bhalodkar
805-679-8845
ir@sientra.com